NCT00619164View on ClinicalTrials.gov

A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome

PHASE2CompletedINTERVENTIONAL

Enrollment

240

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

September 30, 2009

Conditions

Acute Coronary Syndrome

Interventions

DRUG

E5555

E5555, 50 mg (tablet), taken orally, once a day.

DRUG

E5555

E5555, 100 mg (tablet), taken orally, once a day.

DRUG

E5555

E5555, 200 mg (tablet), taken orally, once a day.

DRUG

Placebo

Placebo tablet taken orally, once a day.

Trial Locations (33)

Unknown

Toyoake

Fukuoka

Kasuga

Kitakyushu

Kurume

Gifu

Ōgaki

Fukuyama

Higashi-Hiroshima

Hiroshima

Sapporo

Amagasaki

Himaji

Kobe

Nishinomiya

Kagoshima

Yokohama

Ōmura

Beppu

Urazoe

Osaka

Wako

Komatsushimachō

Bunkyo

Fuchū

Hachiōji

Kodaira

Nerima City

Shinagawa-ku

Shinagawa

Shinjuku

tabashi City

Tanabe

All Listed Sponsors

lead

Eisai Co., Ltd.

INDUSTRY

NCT00619164 - A Double-Blind Study of E5555 in Japanese Patients With Acute Coronary Syndrome | Biotech Hunter | Biotech Hunter